To: Rocko Jack
"Why would a drug company hide a poten market"Possibilities
- "it didn't believe the evidence was strong enough"
- Maybe they had other Alzheimer's drugs they didn't want to upstage.
- Maybe they wanted to get arthritis approval first and didn't want to deal with competing claims about the drug.
- They hate alzeimer's patients.
- They were confused (They have alzeimer's)
- Maybe they are looking for a way to alter it slightly before presenting it as an alzeimer's drug so they can price it differently.
15 posted on
06/05/2019 10:43:03 AM PDT by
DannyTN
To: DannyTN
Pfizer is not the only person with this data. There are numerous companies that have the claims data and can data mine from it. Commercial claims data is harvested and sold back to the drug companies de-identified for patient information on the the regular.
35 posted on
06/05/2019 11:02:08 AM PDT by
statered
("And you know what I mean.")
To: DannyTN
:: They were confused (They have alzeimer’s) ::
You have won the internet! Congrats, bruh.
44 posted on
06/05/2019 11:17:24 AM PDT by
Cletus.D.Yokel
(No dolphins were harmed in the making of this post. They enjoyed the rough handling.)
To: DannyTN
Good list. See my #43 where I postulated your last bullet. The last thing they want is people taking an anti-inflammatory drug to prevent Alzheimers that earns them $1B per year when they could tweak or tune the formulation a bit, make it a separate product, and earn them 10X or 100X that amount.
Your fifth bullet gave me a good laugh — “They were confused (They have alzeimer’s)” LOL.
FreeRepublic.com is powered by software copyright 2000-2008 John Robinson